EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microglial Imaging in Alzheimer’s Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study

Zhengshi Yang, Sarah J Banks, Aaron R Ritter, Jeffrey L Cummings, Karthik Sreenivasan, Jefferson W Kinney, Jessica K Caldwell, Christina G Wong, Justin B Miller, Dietmar Cordes

Journal of Alzheimer's Disease · 06.12.2023 · 96 (4) · 1505-1514

DOI: 10.3233/jad-230631 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, erschienen am 06.12.2023. Verfasst von Zhengshi Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Emerging evidence suggests a potential causal role of neuroinflammation in Alzheimer’s disease (AD). Using positron emission tomography (PET) to image overexpressed 18 kDA translocator protein (TSPO) by activated microglia has gained increasing interest. The uptake of 18F-GE180 TSPO PET was observed to co-localize with inflammatory markers and have a two-stage association with amyloid PET in mice. Very few studies evaluated the diagnostic power of 18F-GE180 PET in AD population and its interpretation in human remains controversial about whether it is a marker of microglial activation or merely reflects disrupted blood-brain barrier integrity in humans.

Objective

The goal of this study was to study human GE180 from the perspective of the previous animal observations.

Methods

With data from twenty-four participants having 18F-GE180 and 18F-AV45 PET scans, we evaluated the group differences of 18F-GE180 uptake between participants with and without cognitive impairment. An association analysis of 18F-GE180 and 18F-AV45 was then conducted to test if the relationship in humans is consistent with the two-stage association in AD mouse model.

Results

Elevated 18F-GE180 was observed in participants with cognitive impairment compared to those with normal cognition. No regions showed reduced 18F-GE180 uptake. Consistent with mouse model, a two-stage association between 18F-GE180 and 18F-AV45 was observed.

Conclusions

18F-GE180 PET imaging showed promising utility in detecting pathological alterations in a symptomatic AD population. Consistent two-stage association between 18F-GE180 and amyloid PET in human and mouse suggested that 18F-GE180 uptake in human might be considerably influenced by microglial activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseHumansMiceAnimalsMicrogliaPositron-Emission TomographyBrainAmyloidAmyloidogenic ProteinsAmyloid beta-PeptidesReceptors, GABAFluorine RadioisotopesIndoles

Stichwörter der Autor:innen

18F-GE180Alzheimer’s diseaseamyloidneuroinflammationtranslocator protein

Substanzen

AmyloidAmyloidogenic ProteinsAmyloid beta-PeptidesReceptors, GABA18F-GE180Fluorine RadioisotopesIndolesTSPO protein, human

Autor:innen und Institutionen

  • Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.
  • Department of Brain Health, University of Nevada Las Vegas, Las Vegas, NV, USA.
  • University of California San Diego, San Diego, CA, USA.
  • Hoag's Pickup Family Neurosciences Institute, Newport Beach, CA, USA.
  • Chambers-Grundy Center for Transformative Neuroscience, Pam Quirk Brain Health and Biomarker Laboratory, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas (UNLV), Las Vegas…
  • Department of Psychology and Neuroscience, University of Colorado, Boulder, CO, USA.

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Yang, Z., Banks, S. J., Ritter, A. R., Cummings, J. L., Sreenivasan, K., Kinney, J. W., Caldwell, J. K., Wong, C. G., Miller, J. B., & Cordes, D. (2023). Microglial Imaging in Alzheimer’s Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study. Journal of Alzheimer's Disease, 96(4), 1505-1514. https://doi.org/10.3233/jad-230631

Vancouver

Yang Z, Banks SJ, Ritter AR, Cummings JL, Sreenivasan K, Kinney JW, et al. Microglial Imaging in Alzheimer’s Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study. Journal of Alzheimer's Disease. 2023;96(4):1505-1514. doi:10.3233/jad-230631

BibTeX
@article{Yang2023,
  author = {Yang, Zhengshi and Banks, Sarah J and Ritter, Aaron R and Cummings, Jeffrey L and Sreenivasan, Karthik and Kinney, Jefferson W and Caldwell, Jessica K and Wong, Christina G and Miller, Justin B and Cordes, Dietmar},
  title = {Microglial Imaging in Alzheimer’s Disease and Its Relationship to Brain Amyloid: A Human 18F-GE180 PET Study},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  volume = {96},
  number = {4},
  pages = {1505--1514},
  doi = {10.3233/jad-230631}
}
Kostenlos starten →